| Parameter |
|
|
| Treatment response, n (%) | Complete response | 1 (3) |
|
| Partial response | 19 (63) |
|
| Stable disease | 5 (17) |
|
| Progression disease | 5 (17) |
| Progression-free survival (months) | Median | 8.1 |
|
| 95% CI | 7.0 - 14.0 |
| Overall survival (months) | Median | 32.7 |
|
| 95% CI | 23.2 - 44.8 |